Form 8-K - Current report:
SEC Accession No. 0001654954-18-007192
Filing Date
2018-06-29
Accepted
2018-06-29 17:00:40
Documents
9
Period of Report
2018-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cvm_8k.htm 8-K 41979
2 ENGAGEMENT AGREEMENT cvm_ex11.htm EX-1.1 55707
3 FORM OF WARRANT (SERIES VV) cvm_ex4u.htm EX-4.(U) 114368
4 PLACEMENT AGENT WARRANT (SERIES WW) cvm_ex4v.htm EX-4.(V) 119374
5 OPINION OF HART & HART, LLC cvm_ex5.htm EX-5 8720
6 SECURITIES PURCHASE AGREEMENT cvm_ex104.htm EX-10.4 253469
7 CONSENT OF HART & HART, LLC cvm_ex23.htm EX-23 5460
8 PRESS RELEASE cvm_ex99.htm EX-99 16461
9 IMAGE cvm_ex99000.jpg GRAPHIC 4257
  Complete submission text file 0001654954-18-007192.txt   622822
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 18929979
SIC: 2836 Biological Products, (No Diagnostic Substances)